Picture of POINT Biopharma Global logo

PNT — POINT Biopharma Global News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Brief: POINT Biopharma Global Reports Qtrly Results Ended June 30

Aug 12 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA GLOBAL INC ANNOUNCES QTRLY RESULTS ENDED
JUNE 30
2022
    * POINT BIOPHARMA GLOBAL INC - QTRLY LOSS PER SHARE OF $0.27

Source text: (https://bit.ly/3QgpEyq)
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on POINT Biopharma Global

See all news